HDAC2 expression was found to differ significantly between malignant prostate cancer focal tissue and adjacent benign paracancerous tissue by immunohistochemical staining, revealing that HDAC2 expression differs in similar tumor cells with different degrees of deterioration [32]. The gene discussed is HDAC2; the disease is prostate cancer.